BR112012005401A2 - agente terapêutico para a dor crônica - Google Patents
agente terapêutico para a dor crônicaInfo
- Publication number
- BR112012005401A2 BR112012005401A2 BR112012005401A BR112012005401A BR112012005401A2 BR 112012005401 A2 BR112012005401 A2 BR 112012005401A2 BR 112012005401 A BR112012005401 A BR 112012005401A BR 112012005401 A BR112012005401 A BR 112012005401A BR 112012005401 A2 BR112012005401 A2 BR 112012005401A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic agent
- chronic pain
- pain
- chronic
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009211021 | 2009-09-11 | ||
PCT/JP2010/053032 WO2011030575A1 (ja) | 2009-09-11 | 2010-02-26 | 慢性疼痛治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012005401A2 true BR112012005401A2 (pt) | 2017-02-21 |
Family
ID=43732252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012005401A BR112012005401A2 (pt) | 2009-09-11 | 2010-02-26 | agente terapêutico para a dor crônica |
Country Status (16)
Country | Link |
---|---|
US (1) | US20120258971A1 (pt) |
JP (2) | JPWO2011030575A1 (pt) |
KR (2) | KR20160147061A (pt) |
AU (1) | AU2010293647B2 (pt) |
BR (1) | BR112012005401A2 (pt) |
CA (1) | CA2773253A1 (pt) |
CO (1) | CO6531434A2 (pt) |
IL (1) | IL218495A0 (pt) |
MX (1) | MX2012002952A (pt) |
MY (1) | MY162348A (pt) |
NZ (1) | NZ599227A (pt) |
RU (1) | RU2555760C2 (pt) |
SG (1) | SG178938A1 (pt) |
TW (1) | TWI465442B (pt) |
UA (1) | UA108862C2 (pt) |
WO (1) | WO2011030575A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
US20190117637A1 (en) * | 2016-06-13 | 2019-04-25 | Board Of Regents Of The University Of Texas System | Pharmaceutical compositions and methods for treatment of pain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54130587A (en) | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
UA80802C2 (en) * | 2001-09-25 | 2007-11-12 | Low hygroscopic aripiprazole drug substance and process for the preparation thereof | |
JP2006514633A (ja) * | 2002-11-26 | 2006-05-11 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 吸入によって送達される抗精神病薬を用いた頭痛の治療 |
US20090198059A1 (en) * | 2004-09-13 | 2009-08-06 | Chava Satyanarayana | Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts |
-
2010
- 2010-02-26 TW TW099105621A patent/TWI465442B/zh not_active IP Right Cessation
- 2010-02-26 KR KR1020167034405A patent/KR20160147061A/ko not_active Application Discontinuation
- 2010-02-26 MX MX2012002952A patent/MX2012002952A/es unknown
- 2010-02-26 US US13/395,364 patent/US20120258971A1/en not_active Abandoned
- 2010-02-26 MY MYPI2012001081A patent/MY162348A/en unknown
- 2010-02-26 RU RU2012114097/15A patent/RU2555760C2/ru not_active IP Right Cessation
- 2010-02-26 NZ NZ599227A patent/NZ599227A/en not_active IP Right Cessation
- 2010-02-26 AU AU2010293647A patent/AU2010293647B2/en not_active Ceased
- 2010-02-26 SG SG2012014569A patent/SG178938A1/en unknown
- 2010-02-26 UA UAA201204551A patent/UA108862C2/uk unknown
- 2010-02-26 CA CA2773253A patent/CA2773253A1/en not_active Abandoned
- 2010-02-26 BR BR112012005401A patent/BR112012005401A2/pt not_active IP Right Cessation
- 2010-02-26 JP JP2011530759A patent/JPWO2011030575A1/ja active Pending
- 2010-02-26 WO PCT/JP2010/053032 patent/WO2011030575A1/ja active Application Filing
- 2010-02-26 KR KR1020127009183A patent/KR20120065392A/ko active IP Right Grant
-
2012
- 2012-03-06 IL IL218495A patent/IL218495A0/en unknown
- 2012-04-10 CO CO12058149A patent/CO6531434A2/es not_active Application Discontinuation
-
2015
- 2015-02-24 JP JP2015034419A patent/JP6025886B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW201109312A (en) | 2011-03-16 |
RU2555760C2 (ru) | 2015-07-10 |
TWI465442B (zh) | 2014-12-21 |
RU2012114097A (ru) | 2013-10-20 |
MX2012002952A (es) | 2012-04-02 |
KR20160147061A (ko) | 2016-12-21 |
NZ599227A (en) | 2014-02-28 |
SG178938A1 (en) | 2012-04-27 |
IL218495A0 (en) | 2012-07-31 |
WO2011030575A1 (ja) | 2011-03-17 |
CA2773253A1 (en) | 2011-03-17 |
AU2010293647A1 (en) | 2012-03-29 |
AU2010293647B2 (en) | 2015-06-25 |
JP2015129160A (ja) | 2015-07-16 |
JP6025886B2 (ja) | 2016-11-16 |
CO6531434A2 (es) | 2012-09-28 |
MY162348A (en) | 2017-06-15 |
KR20120065392A (ko) | 2012-06-20 |
UA108862C2 (uk) | 2015-06-25 |
US20120258971A1 (en) | 2012-10-11 |
JPWO2011030575A1 (ja) | 2013-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181615T1 (hr) | Terapijsko sredstvo koje izaziva citotoksičnost | |
BR112014009634A2 (pt) | preparação e agente terapêutico | |
BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
BRPI0821145A2 (pt) | Agente terapêutico para prurido | |
ATE526024T1 (de) | Fluvoxamin vermeidende pirfenidontheraphy | |
BRPI1014628A2 (pt) | cateter de injeção para enviar um agente terapêutico a um substrato | |
BR112013011874A2 (pt) | compostos e métodos para tratar dor | |
BRPI0819630A2 (pt) | Montagem de interface de paciente para terapia respiratória | |
BR112012031836A2 (pt) | combinação farmacêutica para o tratamento da dor | |
BR112012001819A2 (pt) | métodos para tratamento de dor | |
BR112012000502A2 (pt) | terapia de combinação para o tratamento de diabetes | |
BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
BRPI1008664A2 (pt) | comprimidos para a terapia de combinação | |
BRDI7106622S (pt) | Configuração aplicada em remédio para alívio de dor | |
BR112012009021A2 (pt) | dispositivo de cuidados para tecidos | |
BRPI0906606A2 (pt) | Tratamento terapêutico para condições do pulmão. | |
BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
SMT201600041B (it) | Agenti terapeutici 713 | |
EP2554163A4 (en) | THERAPEUTIC ACTIVE FOR NEURODEGENERATIVE DISEASES | |
BR112015010428A2 (pt) | agente terapêutico para distúrbios ceratoconjuntivos | |
ZA201301458B (en) | Therapeutic agent for pain | |
EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
BRPI1013903A2 (pt) | tratamentos terapêuticos utilizando centaquina | |
GB0900484D0 (en) | Therapeutic agent | |
BR112012013591A2 (pt) | dispositivo para tratamento eletroterapêutico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26/12/2018. |